approved EB-2 (NIW)

Associate Scientist

Biotechnologies · Nepal · 2023-02-22

Processing Time
62 days
Decision Date
2023-02-22
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to study the role of persister cells in cancer and bacterial infections. This work aims to develop and enhance therapeutic approaches specifically targeting drug-resistant forms of these conditions to improve patient outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses drug-resistant forms of cancer and bacterial infections, which is of evident national importance to U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, expertise, and record of 8 publications and 33 citations demonstrate he is well-positioned.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to the healthcare industry justify a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in chemical and biomolecular engineering, 8 peer-reviewed journal articles (5 first-authored), and 33 citations. The case was supported by 4 expert letters and evidence of funding from the National Institute of Allergy and Infectious Diseases (NIAID).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Assistant

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Pennsylvania 109 days 2022-05-02
The petitioner proposes to continue her research in biomedical science, specifically focusing on advancing the understanding of mechanisms behind deadly diseases such as cholera, Salmonella, and COVID-19. Her work involves characterizing complex factors in antibiotic production and resistance to accelerate the development of novel, therapeutically effective antibiotics. The research aims to mitigate the threat of bacterial infections and minimize the prevalence and mortality of infectious diseases in the United States.

Others

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Mississippi 461 days 2025-02-13
The petitioner proposes to continue her research integrating bacterial cell studies with high-throughput sequencing analysis to understand bacterial properties, focusing on natural product generation and bacterial functions to uncover mechanisms for new antibiotics and bioactive compounds.

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.

Clinical Research Coordinator

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Michigan 47 days 2025-05-12
The petitioner proposes to advance disease prevention and treatment strategies, specifically focusing on inflammatory bowel disease, heart disease, autoimmune disorders, and novel infections. The work involves optimizing and synthesizing predictive, therapeutic, and diagnostic modalities to improve clinical outcomes for pressing health issues.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 62 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist